Table 2.
Financial costs of new vaccine introduction in Zambia (2014 US$).
MSD | PCV | RV | Total | Percent of total | |
---|---|---|---|---|---|
Cold storage investments | 228,515 | 505,663 | 1,207,044 | 1,941,223 | 46% |
Social mobilisation | 60,962 | 243,849 | 377,190 | 682,001 | 16% |
Training | 40,398 | 161,591 | 386,824 | 588,813 | 14% |
Tally sheets and under-5 cards | 157,773 | 157,773 | 157,773 | 473,320 | 11% |
Post introduction evaluation | 94,778 | 94,778 | 94,778 | 284,335 | 7% |
Monitoring tools | 32,876 | 131,505 | 76,918 | 241,300 | 6% |
Total | 615,304 | 1,295,161 | 2,300,528 | 4,210,992 | 100% |
Costs per infant in birth cohort | 0.96 | 2.02 | 3.58 | 6.56 | |
Costs per capita | 0.04 | 0.09 | 0.15 | 0.28 |
MSD: Measles second dose, PCV: Pneumococcal conjugate vaccine, RV: Rotavirus vaccine.